This document provides statistics on the activity in 2017 of the Addiction and Mental Health Service of the University Hospital of Sant Joan de Reus. It summarizes data on initial visits, follow-up visits by social workers and nurses, and the number of total users attended by substance. The number of initial visits was 801 and the total number of users in 2017 was 1,744, most being male (78%) and between ages 15-45. The most common substances were heroin, cocaine, alcohol and cannabis. Social workers conducted 766 follow-up visits and nurses provided 1804 follow-up visits and 1152 emergency visits.
Memòria Eix Assistencial 2018infodroguesreusThis document provides statistics and data on the activities carried out in 2018 by the Addiction and Mental Health Service of the Hospital Universitari Sant Joan de Reus. It includes information on initial visits and readmissions by gender and substance, user movements by age, gender and substance, social work activities like initial assessments and follow-up visits, nursing activities like follow-up visits and techniques, the methadone and drug-free treatment programs, inter-consultations, medical visits, dental visits, PIU visits, tobacco consultation, and psychotherapy assistance. Charts and graphs are provided to illustrate trends in user statistics over time.
Memòria Eix Assistencial 2016infodroguesreusThis document summarizes the activities of the Hospital Universitari Sant Joan de Reus Addiction and Mental Health Service in 2016. It provides statistics on patient visits and treatments, including over 1,100 patients receiving psychotherapy and over 4,000 total patient activities. Staffing information is also included listing personnel from various treatment areas like administration, medical, psychology, nursing, and social work. Charts track trends in visits and activities over recent years.
REPORTE PN 2021_ENG.pdfLuisGutirrez360008This sustainability report summarizes Peruvian Nature's operations for 2021, celebrating their 20th anniversary. It discusses their identity, mission, values, sales data, and contributions to sustainability goals. The report also describes their products, suppliers, energy and water use, biodiversity efforts, waste management, employment practices, and occupational health and safety programs. It aims to provide transparency about their economic, social, and environmental performance.
Public Health England: Public awareness and opinion survey 2017Ipsos UKThis is the fourth wave of Public Health England's public opinion research, conducted by Ipsos MORI, following previous waves in 2016, 2015, and a baseline wave in 2014.
Business statistcsMatteo BiaginiThis document analyzes quality of life indicators for G20 countries using statistical analysis methods. It introduces 8 quality of life indicators such as CO2 emissions, health expenditure, and education spending. A correlation matrix shows moderate correlations between some indicators. Regression, factor analysis, and cluster analysis are used to investigate relationships between indicators and group countries based on similarities in quality of life. The analysis finds countries can be grouped according to their quality of life profiles.
Business statistics Matteo BiaginiThis document analyzes quality of life indicators for G20 countries using statistical analysis methods. It introduces 8 quality of life indicators such as CO2 emissions, health expenditure, and education spending. A correlation matrix shows some moderate correlations between indicators. Regression, factor analysis, and cluster analysis are used to investigate relationships between indicators and group countries based on similarities in quality of life. The analysis finds some countries have high quality of life due to factors like education levels and environmental protection.
MEMORIA ASSITENCIAL 2019infodroguesreusThe document summarizes the activities and statistics of the Addiction and Mental Health Service of the Hospital Universitari Sant Joan de Reus in 2019. It discusses the number of new and returning patients, patient demographics, substances involved, social work activities, nursing activities, methadone treatment program details, medical visits, emergencies by substance, and psychotherapy services provided. The key statistics are that 1858 total unique patients were seen in 2019, with the majority being male and between ages 26-45, and cocaine, alcohol, and heroin were the most common substances involved.
Resultat anàlisis enviats a laboratori ec 2017infodroguesreusEnergy Control received resumes from job applicants in 2017. Energy Control provides a harm reduction service that analyzes substances to check for potentially dangerous adulterants. The laboratory aims to promote health, human rights and social justice through its work analyzing substances.
ARSU FESTA MEMÒRIA ACTIVITAT 2017infodroguesreusARSU FESTA MEMÒRIA ACTIVITAT 2017
N. INTERVENCIONS
ALCOHOLIMETRIA
ANÀLISI DE SUBSTÀNCIES
PRESERVATIUS
FESTIVALS
Harm Reduction International 2017 Canadà/Pla accions sobre drogues reusinfodroguesreusResum de la conferència internacional sobre reducció de danys celebrada a Montreal (Canadà, Maig 2017) i la participació del Servei Addiccions i Salut Mental de l'Hospital USJ Reus
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVANThis presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsKHUSHAL CHAVANThis presentation provides a comprehensive overview of optimization in pharmaceutical formulations. It explains the concept of optimization, different types of optimization problems (constrained and unconstrained), and the mathematical principles behind formulation development. Key topics include:
Methods for optimization (Sequential Simplex Method, Classical Mathematical Methods)
Statistical analysis in optimization (Mean, Standard Deviation, Regression, Hypothesis Testing)
Factorial Design & Quality by Design (QbD) for process improvement
Applications of optimization in drug formulation
This resource is beneficial for pharmaceutical scientists, R&D professionals, regulatory experts, and students looking to understand pharmaceutical process optimization and quality by design approaches.
MEMORIA ASSITENCIAL 2019infodroguesreusThe document summarizes the activities and statistics of the Addiction and Mental Health Service of the Hospital Universitari Sant Joan de Reus in 2019. It discusses the number of new and returning patients, patient demographics, substances involved, social work activities, nursing activities, methadone treatment program details, medical visits, emergencies by substance, and psychotherapy services provided. The key statistics are that 1858 total unique patients were seen in 2019, with the majority being male and between ages 26-45, and cocaine, alcohol, and heroin were the most common substances involved.
Resultat anàlisis enviats a laboratori ec 2017infodroguesreusEnergy Control received resumes from job applicants in 2017. Energy Control provides a harm reduction service that analyzes substances to check for potentially dangerous adulterants. The laboratory aims to promote health, human rights and social justice through its work analyzing substances.
ARSU FESTA MEMÒRIA ACTIVITAT 2017infodroguesreusARSU FESTA MEMÒRIA ACTIVITAT 2017
N. INTERVENCIONS
ALCOHOLIMETRIA
ANÀLISI DE SUBSTÀNCIES
PRESERVATIUS
FESTIVALS
Harm Reduction International 2017 Canadà/Pla accions sobre drogues reusinfodroguesreusResum de la conferència internacional sobre reducció de danys celebrada a Montreal (Canadà, Maig 2017) i la participació del Servei Addiccions i Salut Mental de l'Hospital USJ Reus
Solubilization in Pharmaceutical Sciences: Concepts, Mechanisms & Enhancement...KHUSHAL CHAVANThis presentation provides an in-depth understanding of solubilization and its critical role in pharmaceutical formulations. It covers:
Definition & Mechanisms of Solubilization
Role of surfactants, micelles, and bile salts in drug solubility
Factors affecting solubilization (pH, polarity, particle size, temperature, etc.)
Methods to enhance drug solubility (Buffers, Co-solvents, Surfactants, Complexation, Solid Dispersions)
Advanced approaches (Polymorphism, Salt Formation, Co-crystallization, Prodrugs)
This resource is valuable for pharmaceutical scientists, formulation experts, regulatory professionals, and students interested in improving drug solubility and bioavailability.
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsKHUSHAL CHAVANThis presentation provides a comprehensive overview of optimization in pharmaceutical formulations. It explains the concept of optimization, different types of optimization problems (constrained and unconstrained), and the mathematical principles behind formulation development. Key topics include:
Methods for optimization (Sequential Simplex Method, Classical Mathematical Methods)
Statistical analysis in optimization (Mean, Standard Deviation, Regression, Hypothesis Testing)
Factorial Design & Quality by Design (QbD) for process improvement
Applications of optimization in drug formulation
This resource is beneficial for pharmaceutical scientists, R&D professionals, regulatory experts, and students looking to understand pharmaceutical process optimization and quality by design approaches.
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Ganapathi VankudothA complete information of Inflammation, it includes types of Inflammation, purpose of Inflammation, pathogenesis of acute inflammation, chemical mediators in inflammation, types of chronic inflammation, wound healing and Inflammation in skin repair, phases of wound healing, factors influencing wound healing and types of wound healing.
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxWahid HuseinA decade of rabies control programmes in Bali with support from FAO ECTAD Indonesia with Mass Dog Vaccination, Integrated Bite Case Management, Dog Population Management, and Risk Communication as the backbone of the programmes
FAO's Support Rabies Control in Bali_Jul22.pptxWahid HuseinWhat is FAO doing to support rabies control programmes in Bali, Indonesia, using One Health approach with mass dog vaccination and integrated bite case management as main strategies
Non-Invasive ICP Monitoring for NeurosurgeonsDhaval ShuklaThis presentation delves into the latest advancements in non-invasive intracranial pressure (ICP) monitoring techniques, specifically tailored for neurosurgeons. It covers the importance of ICP monitoring in clinical practice, explores various non-invasive methods, and discusses their accuracy, reliability, and clinical applications. Attendees will gain insights into the benefits of non-invasive approaches over traditional invasive methods, including reduced risk of complications and improved patient outcomes. This comprehensive overview is designed to enhance the knowledge and skills of neurosurgeons in managing patients with neurological conditions.
Invasive systems are commonly used for monitoring intracranial pressure (ICP) in traumatic brain injury (TBI) and are considered the gold standard. The availability of invasive ICP monitoring is heterogeneous, and in low- and middle-income settings, these systems are not routinely employed due to high cost or limited accessibility. The aim of this presentation is to develop recommendations to guide monitoring and ICP-driven therapies in TBI using non-invasive ICP (nICP) systems.
Stability of Dosage Forms as per ICH GuidelinesKHUSHAL CHAVANThis presentation covers the stability testing of pharmaceutical dosage forms according to ICH guidelines (Q1A-Q1F). It explains the definition of stability, various testing protocols, storage conditions, and evaluation criteria required for regulatory submissions. Key topics include stress testing, container closure systems, stability commitment, and photostability testing. The guidelines ensure that pharmaceutical products maintain their identity, purity, strength, and efficacy throughout their shelf life. This resource is valuable for pharmaceutical professionals, researchers, and regulatory experts.
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINERelianceNwosuThis presentation emphasizes the role of immunodiagnostics and Immunotherapy.
Cardiac Arrhythmias for paramedical students.helanmariaarockkiasaCardiac Arrhythmia definition, classification, normal sinus rhythm, characteristics , types and management with medical ,surgical & nursing, health education and nursing diagnosis for paramedical students.
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...PVI, PeerView Institute for Medical EducationChair and Presenters Sara A. Hurvitz, MD, FACP, Carey K. Anders, MD, FASCO, and Vyshak Venur, MD, discuss metastatic HER2-positive breast cancer in this CME/NCPD/CPE/AAPA/IPCE activity titled “Fine-Tuning the Selection and Sequencing of HER2-Targeting Therapies in HER2-Positive MBC With and Without CNS Metastases: Expert Guidance on How to Individualize Therapy Based on Latest Evidence, Disease Features, Treatment Characteristics, and Patient Needs and Preferences.” For the full presentation, downloadable Practice Aids, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4f8sUs7. CME/NCPD/CPE/AAPA/IPCE credit will be available until March 2, 2026.
The influence of birth companion in mother care and neonatal outcomeLokesh Kumar Sharmathis content related to birth companionship, role of birth companion in care of mother and neonatal
legal Rights of individual, children and women.pptxRishika RawatA legal right is a claim or entitlement that is recognized and protected by the law. It can also refer to the power or privilege that the law grants to a person. Human rights include the right to life and liberty, freedom from slavery and torture, freedom of opinion and expression, the right to work and education
Flag Screening in Physiotherapy Examination.pptxBALAJI SOMAFlag screening is a crucial part of physiotherapy assessment that helps in identifying medical, psychological, occupational, and social barriers to recovery. Recognizing these flags ensures that physiotherapists make informed decisions, provide holistic care, and refer patients appropriately when necessary. By integrating flag screening into practice, physiotherapists can optimize patient outcomes and prevent chronicity of conditions.
Flag Screening in Physiotherapy Examination.pptxBALAJI SOMA
Memòria Eix Assistencial 2017
1. MEMÒRIA DE L’ACTIVITAT 2017
SERVEI D’ADDICCIONS I SALUT MENTAL
HOSPITAL UNIVERSITARI DE SANT JOAN DE REUS
1
2. ÀREA ADMINISTRATIVA ADMINISTRATIVA
CORI
ATENCIÓ USUARI
PILAR MILAN
ADMINISTRATIVA
VERO GÓMEZ
INFERMERA
PILAR VIDAL
INFERMER
EDU BEAS
AUX CLINICA
MARIBEL OROZCO
AUX CLINICA
JOSEP M. BERNAT
INFERMERA
MERI CORTASA
INFERMERA
ENDA BARBERÀ
ÀREA MÈDICA
METGESSA
DE FAMÍLIA
LOURDES ROFES
METGESSA
INTERNISTA
EULÀLIA SABATER
PSIQUIATRA/
PSICOTERAPEUTA
CAP SASM
TRE BORRÁS
METGESSA
PSIQUIATRA
ROSA SALMONS
ÀREA PSICOLÒGICA
PSICÒLOGA
PILAR ROIG
PSICÒLEG
ARTUR SARDÀ
PSICOTERAPÈUTA
MARI SESMILO
PSICÒLOGA
ESTER MARTOS
ÀREA INFERMERIA
ÀREA SOCIAL
TREB.
SOCIAL
MAR
CRESPI
EDUC.
SOCIAL
MARIA
PARAIRE
TREB.
SOCIAL
ALEX
PEREZ
EDUC.
SOCIAL
SARA
FERRANDO
EDUC.
SOCIAL
TAMARA
GIL
MONITOR
ISABEL
MUÑOZ
MONITORA
MIQUEL
ANGEL
MAGAN
ANTROPOLEG
ANTONI LLORT
MONITOR
MIREIA
BORRULL
Fundació per l’Acció Educativa
HUSJ Suplents HUSJR
SERVEI D’ADDICCIONS I SALUT MENTAL 2017 HUSJR
2
3. SERVEI ADDICCIONS I SALUT MENTAL ACTIVITAT 2017
3
ÀREA ASSISTENCIAL: PRIMERES VISITES
4. 1.-INICIS I REINICIS
4
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
PRIMERES
VISITES
• 484
demandes
de 453
usuaris
• 67,7 %
assistència
VISITES + 1
ANY
• 248
demandes
de 195
usuaris
• 59,2 %
assistència
VISITES + 6
MESOS
• 69
demandes
de 55
usuaris
• 56%
assistència
TOTAL
INICIS
• 801
demandes
de 703
usuaris
• 63,8 %
assistència
10318/ 10719
401 NHC (noves)
5. 1.1.- GÈNERE INICIS I REINICIS
HOMES; 558;
77%
DONES;
162; 23%
GÈNERE INICIS I REINICIS
N=720
5
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
6. 1.2.- EDAT I GÈNERE INICIS I REINICIS
0
50
100
150
200
250
15-25 26-35 36-45 46-55 56-65 >65 NC
EDAT I GÈNERE INICIS I REINICIS
N=691
DONES
HOMES
6
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
7. 1.3.- ASSISTÈNCIA PRIMERES I
REINICIS
SI NO
327
157
146 102
38 31
PRIMERES 1 ANY + 6 MESOS +
ASSISTÈNCIA PRIMERES I REINICIS
7
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
8. 1.4.- ASSISTÈNCIA A LES PRIMERES
VISITES PER SUBSTÀNCIES
47 20
107 73
217
58 35 6 16
31 11
78
16 9 24 31 1 3
ASSISTÈNCIA A LES PRIMERES VISITES PER
SUBSTÀNCIES
N=720
SI NO
8
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
9. 1.5.- ASSISTÈNCIA A PRIMERES VISITES PER
SUBSTÀNCIA COMPARATIVA
0
50
100
150
200
250
300
350
2009 2010 2011 2012 2013 2014 2015 2016 2017
ASSISTÈNCIA A LES PRIMERES VISITES PER
SUBSTÀNCIA COMPARATIVA
N=720
HEROÏNA
COCAÏNA
HER+COC
ALCOHOL
ALC+COC
TABAC
MULTA
THC
ALTRES
9
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
10. 1.6.- EDAT PRIMERES PER SUBSTÀNCIA
0%
20%
40%
60%
80%
100%
15-25 26-35 36-45 46-55 56-65 >65
EDAT PRIMERES PER SUBSTÀNCIA
N=720
ALTRES
THC
MULTA
TABAC
ALC+COC
ALCOHOL
HER+COC
COCAÏNA
HEROÏNA
10
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
14. 2.2.1.-EDAT I GÈNERE USUARIS HEROÏNA
0
50
100
150
15-25 26-35 36-45 46-55 56-65 > 65
N=332
HOMES DONES
14
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
HOMES
81%
DONES
19%
HOMES I DONES
15. 2.2.2.-EDAT I GÈNERE USUARIS HEROÏNA I COCAÏNA
0
20
40
60
80
100
15-25 26-35 36-45 46-55 56-65 > 65
N=196
HOMES DONES
15
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
HOMES
83%
DONES
17%
HOMES I DONES
16. 2.2.3.-EDAT I GÈNERE USUARIS COCAÏNA
0
20
40
60
80
100
120
15-25 26-35 36-45 46-55 56-65 > 65
N=286
HOMES DONES
16
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
HOMES
79%
DONES
21%
HOMES I DONES
17. 2.2.4.-EDAT I GÈNERE USUARIS COCAÏNA I
ALCOHOL
0
20
40
60
80
15-25 26-35 36-45 46-55 56-65 > 65
N=161
HOMES DONES
17
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
HOMES
90%
DONES
10%
HOMES I DONES
18. 2.2.5.-EDAT I GÈNERE USUARIS ALCOHOL
0
50
100
150
200
15-25 26-35 36-45 46-55 56-65 > 65
N=599
HOMES DONES
18
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
HOMES
74%
DONES
26%
HOMES I DONES
19. 2.2.6.-EDAT I GÈNERE USUARIS TABAC
0
5
10
15
20
25
30
15-25 26-35 36-45 46-55 56-65 > 65
N=101
HOMES DONES
19
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
HOMES
56%
DONES
44%
HOMES I DONES
20. 2.2.7.-EDAT I GÈNERE USUARIS THC
0
10
20
30
40
50
60
15-25 26-35 36-45 46-55 56-65 > 65
N=131
HOMES DONES
20
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
HOMES
87%
DONES
13%
HOMES I DONES
23. 2.4.- USUARIS ATESOS PER SUBSTÀNCIA
QUE GENERA LA DEMANDA
RETROSPECTIU
2012
2013
2014
2015
2016
2017
23
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
24. 2.4.- USUARIS ATESOS PER SUBSTÀNCIA
QUE GENERA LA DEMANDA
RETROSPECTIU
2012 2013 2014 2015 2016 2017
HEROÏNA
HER+COC
COC
COC+OH
ALCOHOL
TABAC
THC
MULTA
ALTRES
24
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
26. SERVEI ADDICCIONS I SALUT MENTAL ACTIVITAT 2017
26
ÀREA ASSISTENCIAL:ACTIVITAT SOCIAL
27. 3.-ÀREA ASSISTÈNCIAL:
SOCIALS
PRIMERES MÉS D'UN ANY
293
131
143
93
PRIMERESVISITES I MÉS D’UN ANY
TREBALLADORS SOCIALS
N=574
SI NO
27
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
35. 35
ÀREA ASSITENCIAL: PTM I
PDMF
33
4
41
16
2
MOTIUS ENTRADA AL
PTM
2017
5
47
10 9
1
22
30
4
MOTIUS BAIXA AL PTM
2017
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
36. 36
ÀREA ASSITENCIAL: PTM I
PDMF
TRASLLAT CAS A PETICIÓ
INTERESSAT
2
27
MOTIUS ENTRADA AL
PDMF
2017
5
7
1
13
1
MOTIUS BAIXA AL
PDMF
2017
ACTIVITAT 2016 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
37. ÀREA ASSITENCIAL: PTM I
PDMF
2017 G F M A M J J A S O N D
TOTAL
2017
USUARIS
FINAL MES
PDMF
133 132 137 142 138 147 144 144 140 133 130 131
𝑋=138
USUARIS
FINAL MES
PTM
179 177 176 178 171 175 176 178 172 171 171 175
X=175
PTM+PDMF
312 309 313 320 309 322 320 322 312 304 301 306
̅X=313
37
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
57. 57
ÀREA ASSISTENCIAL: TABAC
SI NO
120
35
41
30
ASSISTÈNCIA VISITES
SEGUIMENT DE TABAC
N=66
HOMES DONES
ALTES
7
VISITES A
PLANTA 8
IMPREVISTOS
22
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
59. ÀREA ASSISTENCIAL:
PSICOTERAPIES
▪HI HA 1215 USUARIS QUE FAN PSICOTERÀPIA
▪1195 FAN TERÀPIA AMB 1 TERAPEUTA
▪76 FAN TERÀPIA AMB 2 TERAPEUTES
▪DELS 1744 USUARIS QUE HAN PASSAT
DURANT EL 2017 PEL SERVEI
UN 70% FAN PSICOTERÀPIA (1215 )
59
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
67. ÀREA ASSISTENCIAL: TERÀPIA
DE GRUP
0
1
2
3
4
5
35-39 40-44 45-49 50-54 55-59
EDAT I GÈNERE DELS USUARIS EN
TERAPIA DE GRUP
N=12
HOMES DONES
67
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
68. ÀREA ASSISTENCIAL: TERÀPIA
DE GRUP
SI
77%
NO
23%
N=12
SI NO
68
ACTIVITAT 2016 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
69. ÀREA ASSISTENCIAL: TERAPIA
DE GRUP
• 77 % SI ASSISTEIXEN
• 23 % NO ASSISTEIXEN
46
SESSIONS
• 9 ALCOHOL
• 1 ALCOHOL I COCAÏNA
• 2 COCAÏNA
12
USUARIS
69
ABANDONEN
3 ALTES
0 CONTINUEN
5 CANVI
TRACTAMENT
4
ACTIVITAT 2017 SERVEI ADDICCIONS I SALUT MENTAL HUSJR
70. SERVEI ADDICCIONS I SALUT MENTAL ACTIVITAT 2017
GRÀCIES UN ANY MÉS
70
ÀREA ASSISTENCIAL